Sur D, Havasi A, Lungulescu C, Volovat S, Burz C, Irimie A. Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review. Medicine and Pharmacy Reports [Internet]. 13May2022 [cited 23Apr.2024];95(3):251-9. Available from: https://medpharmareports.com/index.php/mpr/article/view/2120